Audicin, a Finnish NeuroTech firm that uses music neuroscience and brainwave entrainment for real-time focus, productivity, stress relief, and sleep, has raised €1.6 million.
Private investment, follow-on involvement from Virpi Tuomivaara and Petteri Lahtela, co-founders of Oura Ring, and assistance from Business Finland’s exclusive Deep Tech Accelerator are all included in the round. The funding increases to almost €2.5 million and builds on Audicin’s previous pre-Seed round, which was supported by the founding team of Oura.
Laura Avonius and Dr. Victoria Williamson founded Audicin. The company uses brainwave-entrainment audio protocols based on auditory neuroscience and music psychology to build neurotechnology that supports real-time stress recovery and sleep.
A Medical Advisory Board including Dr. Hannu Kinnunen, former Chief Scientific Officer at Oura; Joel Naukkarinen, MD, an eight-time world champion; and Dr. Jenni Hyysalo supports the company across applied physiology, clinical practice, and wearable analytics.
Laura Avonius, CEO of Audicin, said: “The nervous system doesn’t switch on only when something goes wrong. It’s working all day, adapting to cognitive load, decisions, and stress signals. Audicin is designed to run in the background of real life, helping regulate that load in the moment, not just after the fact. This financing lets us scale into the environments where regulation is hardest to maintain, including phone-restricted settings, and bring this capability into the platforms people already rely on.”
Petteri Lahtela, co-founder of the Oura ring, commented: “Audicin doesn’t depend on user effort or ideal conditions. It functions more like infrastructure: something that can operate during work, rest, and in restricted environments. That’s fundamentally different from tools that require carving out time for wellness, and it’s why we see strong potential both in enterprise deployments and through Audicin for Apps as platforms begin integrating real-time nervous system support directly into their products.”
How Audicin Works:
The company claims that in order to help the brain enter states of relaxation, recuperation, or concentration, its in-house neuroscientists, physicians, audio engineers, and music composers combine their prepared music tracks with real, undetectable binaural beats contained within a 360-degree spatial sound.
Any headphones or earbuds can be used to access Audicin. It is compatible with wearables such as Whoop, Garmin, Apple Watch, and Oura. The company is testing a standalone, offline, Bluetooth-free Sleep Headband with a pre-installed eight-hour recovery program based on a 1Hz delta protocol linked to deep sleep for use in secure, phone-free environments, such as deployments in healthcare and defense settings.
Moreover, the startup offers an SDK called Audicin for Apps, which allows third-party platforms to easily include its recovery processes into their products. The business intends to launch Audicin for Apps and commercialize Audicin’s app and Sleep Headband with the new funding.
Growth and Commercial Progress:
With a €6.9 million sales pipeline covering the defense, athletic performance, and wellness clinic sectors, the company reports strong commercial growth. With a 40% rise in users over a 12-week period and more than doubling iOS revenue in the last 90 days, the company has expanded without paid acquisition since releasing Audicin 2.0 in late 2025. Users average 5.5 sessions per week, with a strong first-week retention rate and a 69% renewal rate, driven by earned discovery and rising demand for Audicin’s offline device.
Austin, Texas is home to Audicin’s go-to-market and commercial operations. Dr. Williamson, a music psychologist and neuroscientist whose work focuses on how sound affects the brain and nervous system, leads research and product development.
